<unk>  Sulphate (1932),<unk>  Compound (1932), and Swan-Myers<unk>  Inhalant No. 66 (circa 1940) Both<unk>  and pseudoephedrine increase blood pressure and act as bronchodilators, with pseudoephedrine having considerably less effect.<unk>  may decrease motion sickness, but it has mainly been used to decrease the sedating effects of other medications used for motion sickness.<unk>  is also found to have quick and long-lasting responsiveness in congenital myasthenic syndrome in early childhood and also even in the adults with a novel COLQ mutation. Weight loss<unk>  promotes modest short-term weight loss, specifically fat loss, but its long-term effects are unknown. In mice,<unk>  is known to stimulate thermogenesis in the brown adipose tissue, but because adult humans have only small amounts of brown fat, thermogenesis is assumed to take place mostly in the skeletal muscle.<unk>  also decreases gastric emptying. Methylxanthines such as caffeine and theophylline have a synergistic effect with<unk>  with respect to weight loss. This led to creation and marketing of compound products. One of them, known as the ECA stack, contains<unk>  with caffeine and aspirin. It is a popular supplement taken by bodybuilders seeking to cut body fat before a competition.
Ephedrine
Pseudoephedrine
Tesofensine
Eptazocine
Dezocine
Naloxone
Butalbital
Bremazocine